|
Volumn 99, Issue 12, 2007, Pages 975-976
|
Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib [4]
f
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
INTERLEUKIN 2;
LEVOTHYROXINE;
LIOTHYRONINE;
PLACEBO;
SOMATOMEDIN C RECEPTOR;
SORAFENIB;
SUNITINIB;
THYROID HORMONE;
THYROTROPIN;
VITRONECTIN RECEPTOR;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
PYRROLE DERIVATIVE;
BRAIN TUMOR;
BREAST CANCER;
CANCER INCIDENCE;
CANCER PATIENT;
CANCER REGRESSION;
CANCER SURVIVAL;
CELL PROLIFERATION;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG INDICATION;
GASTROINTESTINAL STROMAL TUMOR;
HEAD AND NECK CANCER;
HORMONE ACTION;
HORMONE SUBSTITUTION;
HUMAN;
HYPOTHYROIDISM;
KIDNEY CARCINOMA;
LETTER;
LIVER CELL CARCINOMA;
PRESCRIPTION;
PRIORITY JOURNAL;
STATISTICAL SIGNIFICANCE;
THYROID DISEASE;
THYROTROPIN BLOOD LEVEL;
TREATMENT OUTCOME;
TUMOR VASCULARIZATION;
CHEMICALLY INDUCED DISORDER;
KIDNEY TUMOR;
NOTE;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
HORMONE REPLACEMENT THERAPY;
HUMANS;
HYPOTHYROIDISM;
INDOLES;
KIDNEY NEOPLASMS;
PYRROLES;
THYROID HORMONES;
|
EID: 34347268452
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djm008 Document Type: Letter |
Times cited : (17)
|
References (7)
|